23 matches for your search in the start-up spotlight
rssAbselion started in 2018, at that time under the name HexagonFab, in a small corner of a laboratory at the University of Cambridge. We set out with the humble goal to make protein research simpler. Scientists should be able to pursue their passion for discovery and innovation, rather than spend ...
Together, we stand at the brink of a journey, charging forth to redefine energy. Systems-level innovation, born from a decade of shared dedication between world-class technicians, scientists, and experts. We believe in a collaborative approach to innovation and a systems-level approach to ...
Semarion is a spin-out company from the Cavendish Laboratory at the University of Cambridge, operating at the edge of the physical and life sciences. By using microchip industry materials and techniques we are revolutionizing in vitro research on cell models to help create better medicines, ...
Echion Technologies supplies high-power Li-ion battery anode materials that enable superfast charging and low Total Cost of Ownership for the most demanding applications.
Biobot Analytics develops cutting-edge technology to transform sewers into public health observatories. Wastewater contains valuable information about the health of communities. We collect it. We analyze it. We tell you how to leverage it to make your city better. Our first product is to measure ...
At Quench Bio we are discovering inhibitors of novel targets in innate immunity, the gasdermins. A central player in multiple pathways leading to inflammatory cell death, Gasdermin D acts as the executioner of pyroptosis and NETosis. By targeting this core node in innate immunity, we will inhibit ...
The Kebotix self-driving lab combines data and AI with robotics to discover and create advanced chemicals and materials at a faster rate and at the push of a button. Kebotix offers inventive solutions that create new, disruptive chemistries and materials at a rapid pace while reducing costs. Our ...
A cancer diagnosis is something no one wants to hear. Today, it is often detected late, once it has spread and treatment options are often limited. At Thrive Earlier Detection, our goal is to transform this outlook: to catch cancer earlier, when it can be more effectively treated.
nQ Medical's artificial intelligence technology has shown in four years of clinical trials at MIT to substantially change the way disease is managed for a wide range of neuromotor and neurocognitive disorders. nQ focuses on analysis of user interaction with common electronic devices to capture ...
Our scientists help industry-leading companies understand — and capitalize on — the capabilities of quantum computing today, and the possibilities of quantum computing tomorrow. With Fortune Global 1000 companies, we are developing solutions for a wide range of industries including chemistry, ...